Authors:
DUNCIA JV
SANTELLA JB
HIGLEY CA
PITTS WJ
WITYAK J
FRIETZE WE
RANKIN FW
SUN JH
EARL RA
TABAKA AC
TELEHA CA
BLOM KF
FAVATA MF
MANOS EJ
DAULERIO AJ
STRADLEY DA
HORIUCHI K
COPELAND RA
SCHERLE PA
TRZASKOS JM
MAGOLDA RL
TRAINOR GL
WEXLER RR
HOBBS FW
OLSON RE
Citation: Jv. Duncia et al., MEK INHIBITORS - THE CHEMISTRY AND BIOLOGICAL-ACTIVITY OF U0126, ITS ANALOGS, AND CYCLIZATION PRODUCTS, Bioorganic & medicinal chemistry letters, 8(20), 1998, pp. 2839-2844
Authors:
SCHERLE PA
JONES EA
FAVATA MF
DAULERIO AJ
COVINGTON MB
NURNBERG SA
MAGOLDA RL
TRZASKOS JM
Citation: Pa. Scherle et al., INHIBITION OF MAP KINASE KINASE PREVENTS CYTOKINE AND PROSTAGLANDIN E-2 PRODUCTION IN LIPOPOLYSACCHARIDE-STIMULATED MONOCYTES, The Journal of immunology (1950), 161(10), 1998, pp. 5681-5686
Authors:
FAVATA MF
HORIUCHI KY
MANOS EJ
DAULERIO AJ
STRADLEY DA
FEESER WS
VANDYK DE
PITTS WJ
EARL RA
HOBBS F
COPELAND RA
MAGOLDA RL
SCHERLE PA
TRZASKOS JM
Citation: Mf. Favata et al., IDENTIFICATION OF A NOVEL INHIBITOR OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE, The Journal of biological chemistry, 273(29), 1998, pp. 18623-18632
Authors:
DESILVA DR
SCHERLE PA
FAVATA MF
DAULERIO AJ
FESSER WS
JONES EA
STRADLEY DA
BONAK VA
TOWNSEND R
JAFFEE BD
TRZASKOS JM
Citation: Dr. Desilva et al., INHIBITION OF MEK PREVENTS IL2 PRODUCTION, CELL-CYCLE PROGRESSION ANDPROLIFERATION IN T-LYMPHOCYTES, The FASEB journal, 11(9), 1997, pp. 2935-2935